Association of fish consumption and omega 3 supplementation with quality of life, disability and disease activity in an international cohort of people with multiple sclerosis

International Journal of Neuroscience

Volumn 123, Issue 11, 2013, Pages 792-801

  Jelinek, George A ^a,b   Hadgkiss, Emily J ^a   Weiland, Tracey J ^a,c   Pereira, Naresh G ^d   Marck, Claudia H ^a   Van Der Meer, Dania M ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d UNIVERSITY OF NOTRE DAME   (Australia)

Author keywords

MS; Multiple sclerosis; Prevention; Risk factors

Indexed keywords

FISH OIL; LINSEED OIL; OMEGA 3 FATTY ACID;

ADULT; ARTICLE; CLINICAL EVALUATION; DIET SUPPLEMENTATION; DISABILITY; DISEASE ACTIVITY; DISEASE DURATION; ENERGY; FEMALE; FISH MEAT; FOOD INTAKE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MULTIPLE SCLEROSIS; PAIN; QUALITY OF LIFE; RECURRENCE RISK; RISK ASSESSMENT;

ADULT; ANIMALS; COHORT STUDIES; DIETARY SUPPLEMENTS; DISABILITY EVALUATION; DISEASE PROGRESSION; FATTY ACIDS, OMEGA-3; FEMALE; FISHES; HUMANS; INTERNATIONALITY; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; QUALITY OF LIFE; SEAFOOD;

EID: 84885917382     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207454.2013.803104     Document Type: Article

References (35)

1. Hansen T, Skytthe A, Stenager E, et al. Concordance for multiple sclerosis in Danish twins: An update of a nationwide study. Mult Scler 2005;11(5):504-10. PubMed PMID: 16193885.
2. Sawcer S, Hellenthal G, Pirinen M, et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011;476(7359):214-9. Epub 2011 August 13. doi: Nature10251 [pii] 10.1038/nature10251. PubMed PMID: 21833088; PubMed Central PMCID: PMC3182531.
3. Hadgkiss EJ, Jelinek GA,Weiland TJ, et al. Health-related quality of life outcomes at 1 and 5 years after a residential retreat promoting lifestyle modification for people with multiple sclerosis. Neurol Sci 2012. Epub 2012 March 1. doi: 10.1007/s10072-012-0982-4. PubMed PMID: 22367222.
4. Li MP-M, Jelinek GA, Weiland TJ, et al. Effect of a residential retreat promoting lifestyle modifications on health-related quality of life in people with multiple sclerosis. Qual Prim Care 2010;18(6):379-89. PubMed PMID: MEDLINE:21294980.
5. van der Mei IA, Simpson S, Jr., Stankovich J, Taylor BV. Individual and joint action of environmental factors and risk of MS. Neurol Clin 2011;29(2):233-55. Epub 2011 March 29. doi: S0733-8619(10)00160-X [pii] 10.1016/j.ncl.2010.12.007. PubMed PMID: 21439439.
6. Jelinek GA, Hassed CS. Managing multiple sclerosis in primary care: Are we forgetting something?. Qual Prim Care 2009;17(1):55-61. PubMed PMID: MEDLINE:19281675.
7. Erasmus U. Fats that heal, fats that kill: The complete guide to fats, oils, cholesterol and human health. 3rd ed. Summertown, TN: Alive Books; 2010.
8. Simopoulos AP. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr 2002;21(6):495-505. Epub 2002 December 14. PubMed PMID: 12480795.
9. Hadgkiss EJ, Jelinek GA, Weiland TJ, et al. Methodology of an international study of people with multiple sclerosis recruited through web 2.0 platforms: Demographics, lifestyle and disease characteristics. Neurol Res Int 2013; Article ID 580596, 12 pages. Available from: Http://dx.doi.org/10.1155/ 2013/580596, Accessed 3 May 2013.
10. Solari A, Filippini G, Mendozzi L, et al. Validation of Italian multiple sclerosis quality of life 54 questionnaire. J Neurol Neurosurg Psychiatry 1999;67(2):158-62. PubMed PMID: 10406981; PubMed Central PMCID: PMCSource: NLM. PMC1736469.
11. Yamamoto T, Ogata K, Katagishi M, et al. Validation of the Japanese-Translated version Multiple Sclerosis Quality of Life-54 instrument. Rinsho Shinkeigaku - Clin Neurol 2004;44(7):417-21. PubMed PMID: 15384701.
12. Acquadro C, Lafortune L, Mear I. Quality of life in multiple sclerosis: Translation in French Canadian of the MSQoL-54. Health Qual Life Outcomes 2003;1:70. PubMed PMID: 14636427; PubMed Central PMCID: PMCSource: NLM. PMC317365.
13. Hohol MJ, Orav EJ, Weiner HL. Disease steps in multiple sclerosis: A simple approach to evaluate disease progression. Neurology 1995;45(2):251-5. Epub 1995 February 1. PubMed PMID: 7854521.
14. Hohol MJ, Orav EJ, Weiner HL. Disease steps in multiple sclerosis: A longitudinal study comparing disease steps and EDSS to evaluate disease progression. Mult Scler 1999;5(5): 349.
15. Marrie RA, Cutter G, Tyry T, et al. Changes in the ascertainment of multiple sclerosis. Neurology 2005;65(7):1066-70. PubMed PMID: 16217060.
16. Marrie RA, Cutter G, Tyry T, et al. Does multiple sclerosis-Associated disability differ between races?. Neurology 2006;66(8):1235-40. PubMed PMID: 16636241.
17. Hadjimichael O, Vollmer T, Oleen-Burkey M, North American Research Committee on Multiple Sclerosis. Fatigue characteristics in multiple sclerosis: The North American Research Committee on Multiple Sclerosis (NARCOMS) survey. Health Qual Life Outcomes 2008;6:100. PubMed PMID: 19014588; PubMed Central PMCID: PMCSource: NLM. PMC2596785.
18. McKellar S, Horsley P, Chambers R, et al. Development of the diet habits questionnaire for use in cardiac rehabilitation. Australian J Prim Health 2008;14(3):43-7.
19. Swank RL. Multiple sclerosis: A correlation of its incidence with dietary fat. Am J Med Sci 1950;220:421-30.
20. Esparza ML, Sasaki S, Kesteloot H. Nutrition, latitude, and multiple sclerosis mortality: An ecologic study. Am J Epidemiol 1995;142(7):733-7. PubMed PMID: 7572944.
21. Knox EG. Foods and diseases. Br J Prev Soc Med 1977;31(2):71-80. PubMed PMID: 884399.
22. Das UN. Is there a role for saturated and long-chain fatty acids in multiple sclerosis?. Nutrition 2003;19(2):163-6. PubMed PMID: 12591552.
23. Zhang W, Li P, Hu X, et al. Omega-3 polyunsaturated fatty acids in the brain: Metabolism and neuroprotection. Front Biosci 2011;16:2653-70. Epub 2011 May 31. doi: 3878 [pii]. PubMed PMID: 21622201.
24. Gallai V, Sarchielli P, Trequattrini A, et al. Cytokine secretion and eicosanoid production in the peripheral blood mononuclear cells of MS patients undergoing dietary supplementation with n-3 polyunsaturated fatty acids. J Neuroimmunol 1995;56:143-53.
25. D'Hooghe MB, Haentjens P, Nagels G, De Keyser J. Alcohol, coffee, fish, smoking and disease progression in multiple sclerosis. Eur J Neurol 2012;19(4):616-24. Epub 2011 November 29. doi: 10.1111/j.1468-1331.2011.03596.x. PubMed PMID: 22117611.
26. Swank RL, Dugan BB. Effect of low saturated fat diet in early and late cases of multiple sclerosis. Lancet 1990;336(8706):37-9. PubMed PMID: 0001973220.
27. Dworkin RH, Bates D, Millar JH, Paty DW. Linoleic acid and multiple sclerosis: A reanalysis of three double-blind trials. Neurology 1984;34(11):1441-5. PubMed PMID: 6387534.
28. Bates D, Cartlidge NE, French JM, et al. A double-blind controlled trial of long chain n-3 polyunsaturated fatty acids in the treatment of multiple sclerosis. J Neurol Neurosurg Psychiatry 1989;52(1):18-22. PubMed PMID: 2540285.
29. Torkildsen O, Wergeland S, Bakke S, et al. Omega-3 fatty acid treatment in multiple sclerosis (OFAMS Study): A randomized, double-blind, placebo-controlled trial. Arch Neurol 2012;69(8):1044-51. Epub 2012 April 18. doi: Archneurol. 2012.283 [pii] 10.1001/archneurol.2012.283. PubMed PMID: 22507886.
30. Corthals AP. Multiple sclerosis is not a disease of the immune system. Q Rev Biol. 2011;86(4):287-321. Epub 2012 March 6. PubMed PMID: 22384749.
31. Hon GM, Hassan MS, van Rensburg SJ, et al. Red blood cell membrane fluidity in the etiology of multiple sclerosis. J Membr Biol. 2009;232(1-3):25-34. Epub 2009 November 17. doi: 10.1007/s00232-009-9213-1. PubMed PMID: 19915887.
32. Holman RT, Johnson SB, Kokmen E. Deficiencies of polyunsaturated fatty acids and replacement by nonessential fatty acids in plasma lipids in multiple sclerosis. Proc Natl Acad Sci U S A 1989;86:4720-24.
33. Shinto L, Marracci G, Baldauf-Wagner S, et al. Omega-3 fatty acid supplementation decreases matrix metalloproteinase-9 production in relapsing-remitting multiple sclerosis. Prostaglandins Leukot Essent Fatty Acids 2009;80(2-3):131-6. Epub 2009 January 28. doi: S0952-3278(08)00189-0 [pii] 10.1016/j.plefa.2008.12.001. PubMed PMID: 19171471; PubMed Central PMCID: PMC2692605.
34. Marrie RA, Cutter G, Tyry T, et al. Validation of the NARCOMS registry: Diagnosis. Mult Scler 2007;13(6):770-5. Epub 2007 May 26. doi: 1352458506075031 [pii] 10.1177/1352458506075031. PubMed PMID: 17525097.
35. Jelinek G. Overcoming multiple sclerosis: An evidence-based guide to recovery Sydney, New South Wales: Allen and Unwin; 2010.